Matthew B. Frankel
Hoofd Techniek/Wetenschap/O&O bij CHEMOMAB THERAPEUTICS LTD.
Vermogen: - $ op 30-04-2024
Profiel
Matthew B.
Frankel is currently the Chief Medical Officer & VP-Drug Development at Chemomab Therapeutics Ltd.
Prior to this, he worked as the VP-Clinical Development & Medical Affairs at Boehringer Ingelheim Pharmaceuticals, Inc. from 2018 to 2022.
He received his undergraduate degree from Vassar College, his doctorate from David Geffen School of Medicine, and his MBA from Kellogg School of Management.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 28-03-2024 | 0 ( -.--% ) | - $ | 30-04-2024 |
Actieve functies van Matthew B. Frankel
| Bedrijven | Functie | Begin |
|---|---|---|
| CHEMOMAB THERAPEUTICS LTD. | Hoofd Techniek/Wetenschap/O&O | 14-11-2022 |
Eerdere bekende functies van Matthew B. Frankel
| Bedrijven | Functie | Einde |
|---|---|---|
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Hoofd Techniek/Wetenschap/O&O | 01-11-2022 |
Opleiding van Matthew B. Frankel
| Vassar College | Undergraduate Degree |
| David Geffen School of Medicine | Doctorate Degree |
| Kellogg School of Management | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CHEMOMAB THERAPEUTICS LTD. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
